Delivery Order SPE2DB20D3101-SPE2DB22FJ9T3

Award Date 5/31/22
Potential Completion Date 6/1/22
Potential Value $12K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,794.36 for the supply of Epinephrine 0.15 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen), a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,669.87 for the supply of 4554311815 Epinephrine 0.3 mg Auto-Injectors. The award was made by the Defense Logistics Agency (DLA), a defense agency, on August 3, 2021, with an ultimate completion date of August 4, 2021. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,429.48 Firm Fixed Price Delivery Order is for 4,560,941,986 units of Epinephrine 0.3 mg Auto-Inject with a completion date of May 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Delivery Order valued at $11,098.25 for the supply of Epinephrine 0.3 mg Auto-Injector. This Firm Fixed Price contract has a completion date of July 1, 2024 and was awarded on June 28, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,068.74 for the supply of Epinephrine 0.3 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on January 19, 2022, with a completion date of January 20, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Epinephrine 0.3 mg auto-injectors. The $5,794.65 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 5, 2024. Amerisourcebergen is an established pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,794.36 for the supply of 4,560,191,097 units of Epinephrine 0.15 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 9, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $30,660.08 for the supply of 4,564,235,925 units of Epinephrine 0.3 mg Auto-Injectors. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Epinephrine 0.3 mg auto-injectors. The $2,405.55 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 20, 2021. Amerisourcebergen is an established pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,924.56 for the supply of Epinephrine 0.15 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and has an ultimate completion date of January 25, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FJ9T3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,895.93 for the supply of epinephrine 0.15 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 1, 2022.

Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities, to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale.

Generated 2/27/25, 10:09 AM